Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Laboratory for Cell Research and Application (LACRA) is a Japanese biotechnology company focused on the development of regenerative medicine and cell-based therapies. As a subsidiary of ASKA Pharmaceutical Holdings, LACRA leverages advanced induced pluripotent stem cell (iPSC) technology to address unmet needs in reproductive health. The company maintains a strategic collaboration with Kyoto University's Center for iPS Cell Research and Application (CiRA) to translate cutting-edge stem cell research into clinical applications. Their primary pipeline focus involves the creation of iPSC-derived germ cells for the treatment of premature ovarian insufficiency. LACRA operates out of the Life Science Innovation Center in Kawasaki, Japan, positioning itself at the forefront of the country's regenerative medicine ecosystem. By combining ASKA's expertise in hormones and reproductive health with innovative cell technologies, the company aims to provide novel solutions for infertility and related disorders.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Laboratory for Cell Research and Application.